Orano Med LLC

Quick facts

Phase 2 pipeline

• AlphaMedix · Oncology
  AlphaMedix is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell proliferation.

Phase 1 pipeline

• ²¹²Pb-DOTAM-GRPR1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Orano Med LLC portfolio CI brief
• Orano Med LLC pipeline updates RSS